Chimeric adenovirus-based herpes zoster vaccine with the tPA signal peptide elicits a robust T-cell immune response. Jang SO, Lee JH, Chung YJ, Oh HS, et al. Virology 2024;600:110243.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Jang SO, Lee JH, Chung YJ, Oh HS, et al. Chimeric adenovirus-based herpes zoster vaccine with the tPA signal peptide elicits a robust T-cell immune response. Virology 2024;600:110243.
PMID: 39288613